This strategic analysis report examines the joint venture between GlaxoSmithKline (GSK) and Pfizer, focusing on the pharmaceutical industry. The report begins with an introduction and background of both companies, followed by a detailed strategic analysis. The external analysis utilizes PESTEL and Porter's Five Forces models to identify opportunities and threats within the business environment. The internal analysis employs SWOT and VRIO frameworks to assess the companies' strengths, weaknesses, resources, and core competencies. The report then evaluates a recently implemented strategy using the SAFe criteria, including suitability, accessibility, and feasibility. The analysis considers political, economic, social, technological, environmental, and legal factors, as well as competitive forces. The report concludes with an overview of the key findings and strategic recommendations, offering a comprehensive understanding of the strategic landscape of the GSK-Pfizer joint venture.
![[object Object]](/_next/static/media/star-bottom.7253800d.svg)
